Document is current
Any future updates will be listed below
-
Authors
Nguyen, Long V https://orcid.org/0000-0002-3347-438X
Caldas, Carlos https://orcid.org/0000-0003-3547-1489
-
Funding
Funding for this research was provided by:
Cancer Research UK (A16942)
Cancer Research UK (A29580)
European Union Horizon 2020 research and innovation program (ERC‐2015‐AdG‐694620)
European Society for Medical Oncology
American Society of Clinical Oncology
- License Information
-
More Information
Article History
Received: 3 March 2021
Revised: 23 May 2021
Accepted: 10 June 2021
First Online: 13 July 2021
Conflict of interest
: C.C. is a member of AstraZeneca’s iMED External Science Panel, of Illumina’s Scientific Advisory Board, and is a recipient of research grants (administered by the University of Cambridge) from AstraZeneca and Varsity Pharmaceuticals. The other author declares no conflict of interest.
